EP0341860A1
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Benzopyrido piperidine, piperidylidene and piperazine compounds, compositions, methods of manufacture and methods of use
Assignee: Merck Sharp & Dohme LLC
•
Filing: 1989-04-26
•
Granted: —
•
Expires: 2009-04-26
Abstract
Abstract Novel benzopyrido piperidine, piperidylidene and piperazine compounds of the generalized formula are disclosed as useful for the treatment of asthma, allergy and inflammation. Novel pharmaceutical compositions containing such compounds and processes for producing the compounds are also disclosed.
Inventors
- 👤 John J. Piwinski
- 👤 Jesse K. Wong
- 👤 Michael J. Green
- 👤 Ashit K. Ganguly
- 👤 Frank J. Villani
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-04 06:24
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/04; A; A61; A61P; A61P11/00; A61P29/00; A61P37/00; A61P37/08; C07D401/14; C07D491/00; C07D491/02; C07D491/04; C07D495/00; C07D495/02; C07D495/04
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
800 words
A compound represented by the structural formula or a pharmaceutically acceptable salt or solvate thereof, wherein: one of a, b, c and d represents nitrogen or -NR 11 -, where R 11 is -O-, -CH 3 or -(CH 2 )pC0 2 H where p is 1 to 3, and the remaining a, b, c and d groups are CH which may be substituted with R 1 and/or R 2 ; R 1 and R 2 may be the same or different and each independently represents halo, -CF 3 , -OR 10 , -C(O)R 10 , -S-(O) e R 12 where e is 0, 1 or 2, -N(R 10 ) 2 , -N0 2 , SH, CN, OC(O)R 10 , -CO 2 R 10 , -OCO 2 R 12 , -NR 10 C(O)R 10 , alkyl, alkenyl or alkynyl, which alkyl or alkenyl groups may be substituted with halo, -OR 10 or -CO 2 R 10 , or R 1 and R 2 may together form a benzene ring fused to the pyridine ring; R 10 represents H, alkyl or aryl; R 12 represents alkyl or aryl; R 3 and R 4 may be the same or different and each independently represents H or any of the substituents of R' and R 2 , or R 3 and R 4 may be taken together to represent a saturated or unsaturated C S -C 7 ring fused to the benzene ring; R 5 , R 6 , R 7 and R 8 each independently represents H, -CF 3 , -CO 2 R 10 , -C(O)R 10 , alkyl or aryl, which alkyl or aryl may be substituted with -OR 10 , -SR 10 , -N(R 10 ) 2 , -N0 2 , -C(O)R 10 , -OC(O)R 10 , -OCO 2 R 12 , -CO 2 R 10 and -OPO 3 (R 10 ) 2 , or one of R 5 , R 6 , R 7 and R 8 may be taken in combination with R as defined below to represent -(CH 2 ) r -where r is 1 to 4, said combination being optionally substituted with lower alkyl, lower alkoxy, -CF 3 or aryl, or R 5 may be combined with R 6 to represent =O or =S, and/or R 7 may be combined with R 8 to represent = 0 or = S; T represents carbon or nitrogen, with the dotted line attached to T representing an optional double bond when T is carbon; m and n are integers 0, 1, 2, or 3, such that the sum of m plus n equals 0 to 3 with the proviso that: when m plus n equals 1, X represents -O-, -S(O) e - where e is 0, 1 or 2. -NR 10 -, -C(0)NR'°-, NR 10 C(O)-, -C-(S)NR'°-, -NR 10 C(S)-, -C0 2 - or -OC(O)-,- when m plus n equals 2, X represents -O-, -S(O) e - where e is 0, 1 or 2, or -NR 10 -; when m plus n equals 0, X can be any substituent for m plus n equalling 1 and X can also be a direct bond, cyclopropylene, or propenylene; when m plus n equals 3, X equals a direct bond; each R a may be the same or different, and each independently represents H, lower alkyl or phenyl; Z represents =O, = S or =NR 13 where R 13 represents R 10 or CN, such that (a) when Z is 0, R may be taken in combination with R 5 , R 6 , R 7 or R 8 as defined above, or R represents H, alkyl, aryl, -SR 12 , -N(R 10 ) 2 , cycloalkyl, alkenyl, alkynyl or -D wherein -D represents heterocycloalkyl, wherein R 3 and R 4 are as previously defined and W is 0, S or NR 10 and where Y is N or NR 11 , said cycloalkyl, alkyl, alkenyl and alkynyl being optionally substituted with from 1-3 groups selected from halo, -CON(R 10 ) 2 , aryl, -CO 2 R 10 , -OR 14 , -SR 14 , -N(R 10 ) 2 , -N(R 10 )CO 2 R 10 , -COR 14 , -N0 2 or -D, wherein R' 4 represents R 10 , -(CH 2 ) r OR 10 or -(CH 2 ) q CO 2 R 10 and wherein r is 1 to 4 and q is 0 to 4, said alkenyl and alkynyl R groups not containing -OH, -SH or -N(R 10 ) 2 on a carbon in a double or triple bond respectively; (b) when Z represents S, R represents in addition to those R groups above, aryloxy or alkoxy; and (c) when Z represents NR 13 , R represents H, alkyl, aryl, -N(R 10 ) 2 , cycloalkyl, alkenyl or alkynyl.
Claim 2
Dependent Claim
800 words
A compound represented by the structural formula or a pharmaceutically acceptable salt or solvate thereof, wherein: one of a, b, c and d represents nitrogen or -NR 11 -, where R 11 is -O-, -CH 3 or -(CH 2 )pC0 2 H where p is 1 to 3, and the remaining a, b, c and d groups are CH which may be substituted with R 1 and/or R 2 ; R 1 and R 2 may be the same or different and each independently represents halo, -CF 3 , -OR 10 , -C(O)R 10 , -S-(O) e R 12 where e is 0, 1 or 2, -N(R 10 ) 2 , -N0 2 , SH, CN, OC(O)R 10 , -CO 2 R 10 , -OCO 2 R 12 , -NR 10 C(O)R 10 , alkyl, alkenyl or alkynyl, which alkyl or alkenyl groups may be substituted with halo, -OR 10 or -CO 2 R 10 , or R 1 and R 2 may together form a benzene ring fused to the pyridine ring; R 10 represents H, alkyl or aryl; R 12 represents alkyl or aryl; R 3 and R 4 may be the same or different and each independently represents H or any of the substituents of R' and R 2 , or R 3 and R 4 may be taken together to represent a saturated or unsaturated C S -C 7 ring fused to the benzene ring; R 5 , R 6 , R 7 and R 8 each independently represents H, -CF 3 , -CO 2 R 10 , -C(O)R 10 , alkyl or aryl, which alkyl or aryl may be substituted with -OR 10 , -SR 10 , -N(R 10 ) 2 , -N0 2 , -C(O)R 10 , -OC(O)R 10 , -OCO 2 R 12 , -CO 2 R 10 and -OPO 3 (R 10 ) 2 , or one of R 5 , R 6 , R 7 and R 8 may be taken in combination with R as defined below to represent -(CH 2 ) r -where r is 1 to 4, said combination being optionally substituted with lower alkyl, lower alkoxy, -CF 3 or aryl, or R 5 may be combined with R 6 to represent =O or =S, and/or R 7 may be combined with R 8 to represent = 0 or = S; T represents carbon or nitrogen, with the dotted line attached to T representing an optional double bond when T is carbon; m and n are integers 0, 1, 2, or 3, such that the sum of m plus n equals 0 to 3 with the proviso that: when m plus n equals 1, X represents -O-, -S(O) e - where e is 0, 1 or 2. -NR 10 -, -C(0)NR'°-, NR 10 C(O)-, -C-(S)NR'°-, -NR 10 C(S)-, -C0 2 - or -OC(O)-,- when m plus n equals 2, X represents -O-, -S(O) e - where e is 0, 1 or 2, or -NR 10 -; when m plus n equals 0, X can be any substituent for m plus n equalling 1 and X can also be a direct bond, cyclopropylene, or propenylene; when m plus n equals 3, X equals a direct bond; each R a may be the same or different, and each independently represents H, lower alkyl or phenyl; Z represents =O, = S or =NR 13 where R 13 represents R 10 or CN, such that (a) when Z is 0, R may be taken in combination with R 5 , R 6 , R 7 or R 8 as defined above, or R represents H, alkyl, aryl, -SR 12 , -N(R 10 ) 2 , cycloalkyl, alkenyl, alkynyl or -D wherein -D represents heterocycloalkyl, wherein R 3 and R 4 are as previously defined and W is 0, S or NR 10 and where Y is N or NR 11 , said cycloalkyl, alkyl, alkenyl and alkynyl being optionally substituted with from 1-3 groups selected from halo, -CON(R 10 ) 2 , aryl, -CO 2 R 10 , -OR 14 , -SR 14 , -N(R 10 ) 2 , -N(R 10 )CO 2 R 10 , -COR 14 , -N0 2 or -D, wherein R' 4 represents R 10 , -(CH 2 ) r OR 10 or -(CH 2 ) q CO 2 R 10 and wherein r is 1 to 4 and q is 0 to 4, said alkenyl and alkynyl R groups not containing -OH, -SH or -N(R 10 ) 2 on a carbon in a double or triple bond respectively; (b) when Z represents S, R represents in addition to those R groups above, aryloxy or alkoxy; and (c) when Z represents NR 13 , R represents H, alkyl, aryl, -N(R 10 ) 2 , cycloalkyl, alkenyl or alkynyl.
Claim 3
Dependent Claim
33 words
A compound as defined in claim 1 wherein d represents nitrogen or NO, and the a, b and c groups are CH which may be substituted with R 1 or R 2 .
Claim 4
Dependent Claim
28 words
A compound as defined in claim 1 or 2 further characterized by one of R 3 and R 4 being halo, alkyl, -CF 3 or -OR 10 .
Claim 5
Dependent Claim
25 words
A compound as defined in claim 1-3 further characterized by R S , R 6 , R 7 and R 8 being H or alkyl.
Claim 6
Dependent Claim
29 words
A compound as defined in claims 1-4 further characterized by m plus n equalling 1, and X representing -0-, -S(O) e -, where e is 0, 1 or 2.
Claim 7
Dependent Claim
37 words
A compound as defined in claims 1-4 above further characterized by m plus n being zero, and X representing a direct bond, cyclopropylene, propenylene, -0- or -S(O) e - with e equal to 0, 1 or 2.
Claim 8
Dependent Claim
21 words
A compound as defined in claims 1-4 above further characterized m plus n equalling 3 and X being a direct bond.
Claim 9
Dependent Claim
24 words
A compound as defined in claims 1-7 further characterized by T being carbon and the dotted line attached to T representing a double bond.
Claim 10
Dependent Claim
13 words
A compound as defined in claims 1-7 further characterized by T being nitrogen.
Claim 11
Dependent Claim
20 words
A compound as defined in claim 1 further characterized by Z being 0 and R representing H, alkyl, or D.
Claim 12
Dependent Claim
39 words
A compound as defined in claim 1 having the name: 1 acetyl-4-(10H-[1]benzothiopyrano[3,2-b]pyridin-10-ylidene)piperidine; 1-acetyl-4-(8-chloro-5,11-dihydro[1 ]benzoxepino[4,3-b]pyridin-11-ylidene)piperidine; 1-acetyl-4-(1 OH-[1 ]benzopyrano[3,2-b]pyridin-10-y)idene)piperidine; 4-(1 OH[1 ]benzopyrano[3,2-b]pyridin-10-ylidene)-1-piperidine carboxaldehyde; 1-acetyl-4-(5H-[1 ]benzopyrano[2,3-b]pyridin-5-ylidene)piperidine; 1-acetyl-4-(5,6,7,12-tetrahydrobenzo[6,7]cycloocta[1,2-b]pyridin-12-ylidene)piperidine; 1-methoxyacetyl-4-(5,6,7,12-tetrahydrobenzo[6,7]cycloocta[1,2-b]pyridin-12-ylidene)piperidine; 11-(1-acetyl-4-piperidinylidene)-8-chloro-5,11-dihydro-[1 ]-benzothiepino[4,3-b]pyridine; 11-(1-acetyl-4-piperidinylidene)-8-chloro-5,11-dihydro-[1]benzothiepino[4,3-b]pyridine 1,6-dioxide; 11-(1-acetyl-4-piperidinylidene)-8-chloro-5,11-dihydro-[1]-benzothiepino[4,3-b]pyridine 6,6-dioxide; 11-(1-acetyl-4-piperidinylidene)-8-chloro-5,11-dihydro-[1 ]-benzothiepino[4,3-b]pyridine-6-oxide; 11-(1-acetyl-4-piperidinylidene)-8-chloro-5,11-dihydro-[1 ]benzothiepino[4,3-b]pyridine-1,6,6-trioxide; 1-acetyl-4-(9H-indeno[2,1-b]pyridin-9-yl)piperazine; and 1-(4-pyridinylcarbonyl)-4-(5,6,7,12-tetrahydrobenzocycloocta[1,2b]pyridin-12-ylidene)piperidine N'-oxide.
Claim 13
Dependent Claim
30 words
A method of treating asthma, allergy and/or inflammation comprising administering to a mammal in need of such treatment an antiallergic effective amount of a compound as defined in claim 1.
Claim 14
Dependent Claim
21 words
A pharmaceutical composition comprising a compound of formula I as defined in claim 1 in combination with a pharmaceutically acceptable carrier.
Claim 15
Dependent Claim
27 words
The use of a compound of formula I and the pharmaceutically acceptable salts for the preparation of a medicament for the treatment of asthma, allergy and/or inflammation.
Claim 16
Dependent Claim
27 words
The use of a compound of formula I and the pharmaceutically acceptable salts for the preparation of a medicament for the treatment of asthma, allergy and/or inflammation.
Claim 17
Independent Claim
19 words
A method of manufacturing a pharmaceutical composition comprising admixing a compound of formula I with a pharmaceutically acceptable carrier.
Claim 18
Independent Claim
19 words
A method of manufacturing a pharmaceutical composition comprising admixing a compound of formula I with a pharmaceutically acceptable carrier.
Claim 19
Independent Claim
83 words
A method of manufacturing a compound of formula I comprising: A. reacting a compound of formula II with a compound of formula III where L represents a suitable leaving group; B. reacting a compound of formula V with a suitable compound of formula III C. Cyclizing a compound of XLV to a compound of formula I; D. Reacting a compound of formula XXX with a compound of formula XXXII or XXIX to produce a compound of formula I if R C is Z(C)R
Claim 20
Independent Claim
83 words
A method of manufacturing a compound of formula I comprising: A. reacting a compound of formula II with a compound of formula III where L represents a suitable leaving group; B. reacting a compound of formula V with a suitable compound of formula III C. Cyclizing a compound of XLV to a compound of formula I; D. Reacting a compound of formula XXX with a compound of formula XXXII or XXIX to produce a compound of formula I if R C is Z(C)R
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.